Industry
Biotechnology
Topic
Investments
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Investments in Biotechnology
... Hearst, a market leader in healthcare technology, announced an equity investment in M2Gen, a health informatics subsidiary of Moffitt Cancer Center, one of the top ...
... London-based Synthace, the developer of the Antha operating system for biology, has raised $9.6 ...
... per week, in Oxfordshire, UK. The announcement comes as Randal J. Kirk, Intrexon's Chairman and CEO, joined Prime Minister Theresa May at a roundtable event ...
... Synthace Ltd ., the technology company behind the Antha operating system for biology, today ...
... hard to hire new executives. Inside the Equifax hack. VENTURE DEALS [ts_bullet_primary] Sonendo, Inc . , a Laguna Hills, Calif.-based dental technology company, raised $50 ...
... million from Mark Cuban, Y Combinator and other investors. A second company, Biomarker.io, is selling self-reported customer data directly to health and wellness companies to ...
... Boston-based LifeMine Therapeutics, a drug discovery platform provider, has raised $55 million in Series ...
... Cofactor Genomics, developer of a leading platform for RNA sequencing and expression analysis, ...
... Kaleido Biosciences, a clinical-stage biotechnology company developing novel chemistries to unlock the power ...
... in two other companies that have received seed funding from Breakout Labs: Cortexyme and Immusoft. Cortexyme is at work on therapies for Alzheimer’s disease and ...
... Personal genomics startup 23andMe Inc. and quote-to-cash software provider Apttus Inc. are the latest Silicon Valley ...
... San Francisco-based Prellis Biologics, a human tissue engineering startup, has secured $1.8 million in seed ...
... clifton.leaf@fortune.com DIGITAL HEALTH 23andMe raises another $250 million. Silicon Valley genetic testing upstart 23andMe has raised ...
... Silicon Valley startup (and 2017 Fortune Change the World list honoree) 23andMe is on a mission to use your genetic information to conduct unparalleled, ...
... DNA-testing company 23andMe just announced it has secured $250 million in funding. According to a ...
... Silicon Valley-based 23andMe Inc, a consumer genetics and research company, has raised $250 million in ...
... 23andMe, Inc., the leading consumer genetics and research company, today announced it has ...
... go public. Next up was some news that TechCrunch broke this week: 23andMe is raising around $200 million at a $1.5 billion pre-money valuation. That ...
... UK-based Replimune, a developer of oncolytic immunotherapy, has closed $55 million in Series B ...
... Replimune Group Inc., a biotechnology company focused on developing next generation oncolytic immunotherapies, announced ...
... in March 2016 and THR-149, which resulted from a research collaboration with Bicycle Therapeutics. These products all have different modes of action and will allow ...
... AMAL Therapeutics (AMAL), a venture leader and Venture Kick alumnus was under the ...
... mobile applications, wireless infrastructure, semiconductors & materials, and software (including SaaS). About Anges Québec Capital (http://www.angesquebec.com)Anges Québec Capital is an investment fund created to provide ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤